For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Zoetis Inc (NYSE: ZTS) closed the day trading at $120.41 down -1.76% from the previous closing price of $122.57. In other words, the price has decreased by -$1.76 from its previous closing price. On the day, 4.94 million shares were traded. ZTS stock price reached its highest trading level at $123.31 during the session, while it also had its lowest trading level at $119.76.
Ratios:
For a better understanding of ZTS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 25.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.69. For the most recent quarter (mrq), Quick Ratio is recorded 2.28 and its Current Ratio is at 3.64. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.35.
On July 17, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $155.
Stifel Downgraded its Buy to Hold on June 18, 2025, while the target price for the stock was maintained at $160.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’25 when Lagano Roxanne sold 652 shares for $170.00 per share. The transaction valued at 110,840 led to the insider holds 15,129 shares of the business.
Lagano Roxanne bought 652 shares of ZTS for $110,840 on Jun 03 ’25. On Mar 11 ’25, another insider, Reed Willie M, who serves as the Director of the company, bought 1,210 shares for $166.14 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 53363724288 and an Enterprise Value of 58269868032. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.29, and their Forward P/E ratio for the next fiscal year is 17.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.65 while its Price-to-Book (P/B) ratio in mrq is 9.85. Its current Enterprise Value per Revenue stands at 6.201 whereas that against EBITDA is 14.6.
Stock Price History:
The Beta on a monthly basis for ZTS is 0.97, which has changed by -0.305395 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, ZTS has reached a high of $181.85, while it has fallen to a 52-week low of $115.25. The 50-Day Moving Average of the stock is -10.49%, while the 200-Day Moving Average is calculated to be -20.44%.
Shares Statistics:
Over the past 3-months, ZTS traded about 3.78M shares per day on average, while over the past 10 days, ZTS traded about 5106530 shares per day. A total of 441.46M shares are outstanding, with a floating share count of 439.89M. Insiders hold about 0.18% of the company’s shares, while institutions hold 96.85% stake in the company. Shares short for ZTS as of 1763078400 were 8251796 with a Short Ratio of 2.18, compared to 1760486400 on 8734430. Therefore, it implies a Short% of Shares Outstanding of 8251796 and a Short% of Float of 1.87.
Dividends & Splits
ZTS’s forward annual dividend rate is 2.00, up from 1.932 a year ago. Against a Trailing Annual Dividend Yield of 0.015762422. The stock’s 5-year Average Dividend Yield is 0.82.
Earnings Estimates
. The current rating of Zoetis Inc (ZTS) reflects the combined expertise of 15.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $1.57, with high estimates of $1.62 and low estimates of $1.51.
Analysts are recommending an EPS of between $6.38 and $6.3 for the fiscal current year, implying an average EPS of $6.34. EPS for the following year is $6.79, with 19.0 analysts recommending between $6.96 and $6.43.
Revenue Estimates
13 analysts predict $2.36B in revenue for. The current quarter. It ranges from a high estimate of $2.39B to a low estimate of $2.34B. As of. The current estimate, Zoetis Inc’s year-ago sales were $2.32BFor the next quarter, 13 analysts are estimating revenue of $2.33B. There is a high estimate of $2.36B for the next quarter, whereas the lowest estimate is $2.27B.
A total of 16 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $9.53B, while the lowest revenue estimate was $9.42B, resulting in an average revenue estimate of $9.45B. In the same quarter a year ago, actual revenue was $9.26BBased on 17 analysts’ estimates, the company’s revenue will be $9.94B in the next fiscal year. The high estimate is $10.13B and the low estimate is $9.74B.
